Consultation on the Legislative Review of the Tobacco and Vaping Products Act
Publication date:
2022
Author:
Canadian Centre on Substance Use and Addiction
Submitted to Health Canada in April 2022.
Summarizes CCSA’s feedback on Health Canada’s consultation on the legislative review of the Tobacco and Vaping Products Act. Discusses the rise of vaping among young cannabis users and why it is important to maintain the existing list of prohibited ingredients and aromas in the act. The submission supports maintaining an evidence-based public health approach to cannabis regulation, including continued oversight to protect young people from the risks of vaping products.